Overview

Headache Inducing Effect of Levcromakalim in Migraine With Aura Patients

Status:
Completed
Trial end date:
2019-12-10
Target enrollment:
0
Participant gender:
All
Summary
To investigate the role of KATP channels in migraine with aura patients.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Danish Headache Center
Treatments:
Cromakalim
Criteria
Inclusion Criteria:

- Migraine with aura patients of both sexes.

- 18-60 years.

- 50-100 kg.

Exclusion Criteria:

- Headache less than 48 hours before the tests start

- Daily consumption of drugs of any kind other than oral contraceptives

- Pregnant or nursing women.

- Cardiovascular disease of any kind, including cerebrovascular diseases.